WO2011126301A3 - 근육 타입 변화를 촉진하는 조성물 - Google Patents

근육 타입 변화를 촉진하는 조성물 Download PDF

Info

Publication number
WO2011126301A3
WO2011126301A3 PCT/KR2011/002413 KR2011002413W WO2011126301A3 WO 2011126301 A3 WO2011126301 A3 WO 2011126301A3 KR 2011002413 W KR2011002413 W KR 2011002413W WO 2011126301 A3 WO2011126301 A3 WO 2011126301A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
muscle
promoter
muscle type
accelerating
Prior art date
Application number
PCT/KR2011/002413
Other languages
English (en)
French (fr)
Other versions
WO2011126301A2 (ko
Inventor
조시영
이지해
배일홍
송민정
여현주
서대방
김완기
이상준
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to US13/638,813 priority Critical patent/US8652538B2/en
Priority to CN201180028017.2A priority patent/CN102933222B/zh
Publication of WO2011126301A2 publication Critical patent/WO2011126301A2/ko
Publication of WO2011126301A3 publication Critical patent/WO2011126301A3/ko
Priority to US14/147,102 priority patent/US9084785B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/424—Gynostemma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9064—Amomum, e.g. round cardamom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 PPAR-δ 활성 촉진 물질, AMPK 활성 촉진 물질 및 PGC1-α 활성 촉진 물질을 유효 성분으로 포함하는 근육 타입 변화 촉진, 근육량 증가, 근육 강 화, 운동 능력 향상, 지질 감소, 지질 축적 억제, 혈당 감소, 체중 조절 또는 체중 감소용 조성물을 제공한다.
PCT/KR2011/002413 2010-04-06 2011-04-06 근육 타입 변화를 촉진하는 조성물 WO2011126301A2 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/638,813 US8652538B2 (en) 2010-04-06 2011-04-06 Composition for accelerating change in muscle type
CN201180028017.2A CN102933222B (zh) 2010-04-06 2011-04-06 加速肌肉类型转变的组合物
US14/147,102 US9084785B2 (en) 2010-04-06 2014-01-03 Composition for accelerating change in muscle type

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0031473 2010-04-06
KR1020100031473A KR101372037B1 (ko) 2010-04-06 2010-04-06 근육 타입 변화를 촉진하는 조성물

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/638,813 A-371-Of-International US8652538B2 (en) 2010-04-06 2011-04-06 Composition for accelerating change in muscle type
US14/147,102 Division US9084785B2 (en) 2010-04-06 2014-01-03 Composition for accelerating change in muscle type

Publications (2)

Publication Number Publication Date
WO2011126301A2 WO2011126301A2 (ko) 2011-10-13
WO2011126301A3 true WO2011126301A3 (ko) 2012-03-08

Family

ID=44763406

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/002413 WO2011126301A2 (ko) 2010-04-06 2011-04-06 근육 타입 변화를 촉진하는 조성물

Country Status (4)

Country Link
US (2) US8652538B2 (ko)
KR (1) KR101372037B1 (ko)
CN (2) CN102933222B (ko)
WO (1) WO2011126301A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780061B2 (en) 2014-09-26 2020-09-22 Daegu Gyeongbuk Institute Of Science And Technology Composition comprising farnesol and use thereof
TWI671081B (zh) * 2017-04-03 2019-09-11 大江生醫股份有限公司 用以提升轉谷氨醯胺酶１基因、角蛋白基因、水通道蛋白３基因、聚角蛋白微絲基因、葡萄糖腦苷酯酶基因、及玻尿酸合成酶基因表現之含有植物萃取物之組成物的用途
WO2022139544A1 (ko) * 2020-12-24 2022-06-30 고려대학교 산학협력단 아로니아 또는 어성초 추출물을 유효성분으로 함유하는 근육질환 예방 또는 치료용 조성물
KR102602269B1 (ko) 2020-12-30 2023-11-21 주식회사 홀리스틱바이오 시링가레시놀(Syringaresinol)과 레스베라트롤(Resveratrol)을 포함하는 근육 질환 예방 또는 치료용 조성물

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070004999A (ko) * 2004-04-26 2007-01-09 쇼와 덴코 가부시키가이샤 토코페롤 유도체, 아스코르브산 유도체 및 리포펩티드구조를 갖는 계면활성제를 함유하는 피부 외용제
KR100818586B1 (ko) * 2003-12-30 2008-04-01 주식회사 케이티앤지 대사활성을 촉진시키는 탄시논 유도체를 유효성분으로함유하는 비만 및 대사증후군 치료제
KR20090113554A (ko) * 2008-04-28 2009-11-02 한국생명공학연구원 토별충 추출물 또는 이의 분획물을 유효성분으로 함유하는비만 또는 동맥경화 예방 및 치료용 조성물
US20100260733A1 (en) * 2009-04-10 2010-10-14 Haiyan Qi Novel anti aging agents and methods to identify them
US20110138488A1 (en) * 2008-06-25 2011-06-09 Yi Zhang Deficiency in the histone demethylase jhdm2a results in impaired energy expenditure and obesity
US20110144009A1 (en) * 2008-05-27 2011-06-16 Boss Olivier D Brown Adipocyte Progenitors in Human Skeletal Muscle
KR20110080470A (ko) * 2010-01-06 2011-07-13 (주)아모레퍼시픽 홍삼 추출물 및 약초 발효물을 함유하는 면역 증강용 또는 항산화용 건강식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002102364A1 (ja) * 2001-06-18 2004-09-30 山田　幸子 ＰＰＡＲγ作動性医薬組成物
US20040131648A1 (en) * 2002-10-24 2004-07-08 The Procter & Gamble Company Nuclear hormone receptor compounds, products and methods employing same
US20060246163A1 (en) * 2005-04-27 2006-11-02 Tg Biotech Treatment of insulin resistance syndrome
CN101455354A (zh) * 2007-12-14 2009-06-17 中国科学院微生物研究所 天然菌草保肝解酒剂
JP2009256309A (ja) * 2008-03-17 2009-11-05 Oriza Yuka Kk 脂肪代謝改善遺伝子発現促進剤および糖尿病予防関連遺伝子発現促進剤

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100818586B1 (ko) * 2003-12-30 2008-04-01 주식회사 케이티앤지 대사활성을 촉진시키는 탄시논 유도체를 유효성분으로함유하는 비만 및 대사증후군 치료제
KR20070004999A (ko) * 2004-04-26 2007-01-09 쇼와 덴코 가부시키가이샤 토코페롤 유도체, 아스코르브산 유도체 및 리포펩티드구조를 갖는 계면활성제를 함유하는 피부 외용제
KR20090113554A (ko) * 2008-04-28 2009-11-02 한국생명공학연구원 토별충 추출물 또는 이의 분획물을 유효성분으로 함유하는비만 또는 동맥경화 예방 및 치료용 조성물
US20110144009A1 (en) * 2008-05-27 2011-06-16 Boss Olivier D Brown Adipocyte Progenitors in Human Skeletal Muscle
US20110138488A1 (en) * 2008-06-25 2011-06-09 Yi Zhang Deficiency in the histone demethylase jhdm2a results in impaired energy expenditure and obesity
US20100260733A1 (en) * 2009-04-10 2010-10-14 Haiyan Qi Novel anti aging agents and methods to identify them
KR20110080470A (ko) * 2010-01-06 2011-07-13 (주)아모레퍼시픽 홍삼 추출물 및 약초 발효물을 함유하는 면역 증강용 또는 항산화용 건강식품 조성물

Also Published As

Publication number Publication date
US20130017280A1 (en) 2013-01-17
CN102933222B (zh) 2015-02-04
US20140120187A1 (en) 2014-05-01
WO2011126301A2 (ko) 2011-10-13
CN102933222A (zh) 2013-02-13
CN104644727A (zh) 2015-05-27
KR101372037B1 (ko) 2014-03-10
CN104644727B (zh) 2018-12-25
US9084785B2 (en) 2015-07-21
KR20110112072A (ko) 2011-10-12
US8652538B2 (en) 2014-02-18

Similar Documents

Publication Publication Date Title
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
WO2012103038A3 (en) Nanoparticle compositions, formulations thereof, and uses therefor
WO2008083157A3 (en) Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
WO2013103919A3 (en) Compositions and methods for treating metabolic disorders
WO2013178965A3 (fr) Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau
WO2012156296A8 (en) Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2010087565A3 (ko) 피페린의 신규한 용도
WO2010080756A3 (en) Harmine derivatives for reducing body weight
EP2438923A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY-RELATED DISORDERS MEDIATED BY AMPK ACTIVATION AND THE ACTIVE INGREDIENTS OF WHICH HAVE 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS
PL2531189T3 (pl) Kompozycja kombinacyjna zawierająca jako składniki czynne L-karnitynę lub propionylo-L-karnitynę do zapobiegania lub leczenia przewlekłej niewydolności żylnej
WO2011126301A3 (ko) 근육 타입 변화를 촉진하는 조성물
IL208751A0 (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood
WO2013009851A3 (en) Oxidation resistant bioprosthetic tissues and preparation thereof
WO2009038095A1 (ja) セサミン類とビタミンｂ１類とを配合した組成物
WO2008155998A1 (ja) 抗不安抗うつ剤
FR2972330B1 (fr) Composition nutraceutique pour limiter l'absorption de lipides alimentaires et pour induire une perte de poids comprenant comme agent actif au moins un extrait de carotte.
WO2013025073A3 (ko) 유홍초 추출물을 함유하는 당뇨합병증 예방 또는 치료용 조성물
WO2013170086A3 (en) Formulations for the delivery of active ingredients
WO2011141113A3 (de) Kombination aus vitamin k und nikotinamid
MX2013006356A (es) Composicion de relleno que comprende grano integral hidrolizado.
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
WO2013000895A9 (en) Dha and epa in the reduction of oxidative stress
EP2875823A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHIES CONTAINING HENOSIS STAPF EXTRACT FROM VAR. MUNRO OF PHYLLOSTACHYS NIGRA AS ACTIVE INGREDIENT
WO2012105816A3 (ko) 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180028017.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11766152

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13638813

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11766152

Country of ref document: EP

Kind code of ref document: A2